Abstract
A syndrome akin to graft-versus-host disease in the recipient of syngeneic stem cells is hitherto described as being milder, self-limiting and confined to the skin. It is enhanced by prior cyclosporin A therapy. We describe here a recipient of a syngeneic marrow transplant who did not receive priming with cyclosporin A and yet developed severe and progressive graft-versus-host disease which necessitated and responded to high-dose immunosuppressive therapy. We believe that this is because the conditioning regimen in stem cell transplant acts to reset the immune system enabling it to recognise ‘self’ antigens. Bone Marrow Transplantation (2000) 25, 205–207.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Einsele H, Ehninger G, Schneider EM et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation Transplantation 1988 45: 579–585
Rappeport J, Mihm M, Reinherz E et al. Acute graft-versus-host disease in recipients of bone marrow from identical twin donors Lancet 1979 ii: 717–720
Jones RJ, Voselgang GB, Hess AD et al. Induction of graft-versus-host disease after autologous bone marrow transplantation Lancet 1989 1: 754–757
Hess AD, Thoburn CJ . Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease Immunol Rev 1997 157: 111–123
Barredo JC, Yusuf U, Hahn A et al. Progressive autologous graft-versus-host disease induced by cyclosporin A Bone Marrow Transplant 1996 18: 659–662
Appleton AL, Sviland L, Wilkes J et al. Late development of graft-versus-host disease in an autologous BMT recipient Bone Marrow Transplant 1994 13: 823–825
Jenkins MK, Schwartz RH, Pardoll DM . Effects of cyclosporin A on T cell development and clonal deletion Science 1988 241: 1655–1658
Wolin MJ, Rigor RL . Acute graft-versus-host disease in a recipient of a twin blood cell transplant Bone Marrow Transplant 1996 17: 125–126
Billingham RE . The Biology of Graft-versus-Host Reactions The Harvey Lectures vol 62: Academic Press: New York 1966 pp 21–78
Ferrara J, Burakoff S . The pathophysiology of acute graft-versus-host disease in a murine bone marrow transplant model. In: Burakoff S, Deeg HJ, Ferrara J, Atkinson K (eds) Graft-versus-Host Disease: Immunology, Pathophysiology and Treatment New York: Marcel Dekker 1990 p. 9
Johnson BD, Drobyski WR, Truitt RL . Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease Bone Marrow Transplant 1993 11: 329–336
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hwang, W., Goh, Y., Tan, C. et al. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy. Bone Marrow Transplant 25, 205–207 (2000). https://doi.org/10.1038/sj.bmt.1702115
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702115